Additional experiments demonstrated that tetracyclines also decrease the production of IL-1β and IL-18 by ex-vivo-studied alveolar leukocytes from patients with direct ARDS, suggesting a potential role for tetracyclines in the treatment of ARDS associated with elevated caspase-1 activity [50] (Table 1). Here, CASP1 is linked to acute respiratory distress syndrome.